AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Lab Thread Ltd, a UK-based life science software company, today announced the beta launch of its flagship unified lab ...
A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...
High-resolution imaging has revealed the internal layout of chromatin condensates, showing how DNA fibers fold and interact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results